Skip to content

VISUAL OUTCOMES AFTER BILATERAL SURGICAL CATARACT PHACOEMULSIFICATION: ACRYSOF® RESTOR IOL IMPLANTATION COMPARED TO MONOFOCAL IOL IMPLANTATION

VISUAL OUTCOMES AFTER BILATERAL SURGICAL CATARACT PHACOEMULSIFICATION: ACRYSOF® RESTOR IOL IMPLANTATION COMPARED TO MONOFOCAL IOL IMPLANTATION - Alcon RDG-10-269

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36197
Enrollment
30
Registered
2011-03-24
Start date
2011-04-26
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract corneaal astigmatism

Interventions

There are 2 groups of subjects: Group 1 will receive commercially available, CE marked, AcrySof ReSTOR IOL models (SN6AD1 and SND1T2 through SND1T5) Group 2 will receive Monofocal IOLs (commercially

Sponsors

Alcon Laboratories
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Ocular criteria must be met in both eyes; >= 21 years of age; willing and able to attend postoperative examinations as per protocol schedule; have bilateral, age-related, cataracts; have planned cataract removal via phacoemulsification with implantation of an IOL; are available to undergo second eye surgery within 6 weeks of the first eye surgery; fulfils the recommendations at the *Warnings* and *Precautions* sections of the AcrySof ReSTOR IOL and Monofocal IOL package inserts; have either no pre-operative corneal astigmatism or pre-operative regular corneal astigmatism

Exclusion criteria

Exclusion criteria: If any of the following exclusion criteria are applicable to either eye, the subject shall not be enrolled in the study; previous corneal surgery and/or reshaping; abnormality, disease and/or conditions of the cornea (i.e. keratoconus, corneal dystrophy, severe keratitis, corneal scar, etc.), which would clinically contra-indicate the implantation of a toric intraocular lens; planned multiple procedures during cataract/IOL implantation surgery; planned limbal relaxing incision (LRI), Excimer laser treatment or similar procedure prior to or during the course of the study;

Design outcomes

Primary

MeasureTime frame
bilateral uncorrected distance visual acuity and bilateral uncorrected near visual acuity

Secondary

MeasureTime frame
Costs of postoperative spectacle correction

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)